Cholangiocarcinoma Market: Overview
Cholangiocarcinoma is a type of cancer forming in the bile ducts inside the stomach that carries the digestive fluid bile. Bile ducts link our liver on our gallbladder and in the small gut. This condition, also known as bile duct cancer, is an unusual form of most cancers that occurs typically in humans older than 50 years of age, even though it can happen at any age. The rising number of digestive issues among the aged population is considered a prime factor augmenting the growth of this market during the forecast period, 2020 to 2030.
The global cholangiocarcinoma market is classified on the basis of treatment type, distribution channel, and region. In terms of region, the market is divided into chemotherapy, targeted therapy, and immunotherapy. Among these, the chemotherapy is further segmented into 5 fluorouracil, capecitabine, oxaliplatin, cisplatin, and gemcitabine. The targeted therapy segment is further classified into ivosidenib, infigratinib, and pemigatinib. The immunotherapy segment is again categorized into pembrolizumab, and others. With respect to segmentation by distribution channel, the global market for cholangiocarcinoma is divided into retail pharmaceies, hospital pharmacies, and online pharmacies.
The report is based on qualitative and quantitative analysis of the market and its prime growth trajectories including the recent trends and innovations along with restraints and drivers. It also throws light on the impact of the novel Coronavirus on this market and what measures can be adopted to help this market continue earning handsome revenues at the time of a worldwide pandemic. Furthermore, the report emphasizes on the table of segmentation and mentions the leading segment with factors attributing to its growth. The report is available for sale on the company website.
Cholangiocarcinoma Market: Company Profiles
Major manufacturers of the global cholangiocarcinoma market are indulging in strategic collaborations to gain an upper hand in the overall market competition. Apart from this, some other players are investing in research and development of better therapeutics to treat various cancer types especially cancer of the bile duct.
Some of the notable players of the global cholangiocarcinoma market include:
Delcath Systems Inc.
Imbrium Therapeutics L.P.
Incyte Corporation
Ability Pharmaceuticals
RenovoRx,
Agios Pharmaceuticals, Inc.
QED Therapeutics, Inc.
Eisai Co., Ltd.
Buy This Report @ https://www.tmrresearch.com/checkout?rep_id=7484
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to busi-ness entities keen on succeeding in today’s supercharged economic climate. Armed with an experi-enced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Media Contact
Company Name: TMR Research
Contact Person: Rohit Bhisey
Email:Send Email
Phone: +1-415-520-1050
City: San Francisco
State: CA
Country: United States
Website: https://www.tmrresearch.com
